In conclusion, our data show that PLAU is induced in NSCLC cells with ARID1A loss and promotes NSCLC cell growth, survival, and cisplatin resistance through stabilization of TM4SF1. This evidence concerns the gene PLAU and non-small cell lung carcinoma.